SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-078317
Filing Date
2015-11-12
Accepted
2015-11-12 16:23:42
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-17893_110q.htm 10-Q 928465
2 EX-31.1 a15-17893_1ex31d1.htm EX-31.1 11247
3 EX-31.2 a15-17893_1ex31d2.htm EX-31.2 11239
4 EX-32 a15-17893_1ex32.htm EX-32 10623
  Complete submission text file 0001104659-15-078317.txt   3383130

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT tbph-20150930.xml EX-101.INS 563562
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tbph-20150930.xsd EX-101.SCH 33716
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tbph-20150930_cal.xml EX-101.CAL 43508
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tbph-20150930_def.xml EX-101.DEF 88921
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tbph-20150930_lab.xml EX-101.LAB 284237
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tbph-20150930_pre.xml EX-101.PRE 187124
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36033 | Film No.: 151225134
SIC: 2834 Pharmaceutical Preparations